Junxing Chay

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Combination Therapy

Benign Prostatic Hyperplasia

Top Venues

Journal of the American Heart Association

Nephrology (Carlton, Vic.)

Eye (London, England)

Health economics

This page only lists publications with an associated author ORCID identifier.

Publications

Junxing Chay, Tazeen Hasan Jafar, Rebecca Jade Su, Rupesh Madhukar Shirore, Ngiap Chuan Tan, Eric Andrew Finkelstein
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension. Journal of the American Heart Association 13 (8) (2024)
Junxing Chay, Jason Chon Jun Choo, Eric Andrew Finkelstein
Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore. Nephrology (Carlton, Vic.) 29 (5) (2024)
Junxing Chay, Jason Chon Jun Choo, Eric Andrew Finkelstein
Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore. Nephrology (Carlton, Vic.) (2024)
Junxing Chay, Tazeen Hasan Jafar, Rebecca Jade Su, Rupesh Madhukar Shirore, Ngiap Chuan Tan, Eric Andrew Finkelstein
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension. Journal of the American Heart Association 13 (8) (2024)
Junxing Chay, Jason Chon Jun Choo, Eric Andrew Finkelstein
Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore. Nephrology (Carlton, Vic.) (2024)
Junxing Chay, Tazeen Hasan Jafar, Rebecca Jade Su, Rupesh Madhukar Shirore, Ngiap Chuan Tan, Eric Andrew Finkelstein
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension. Journal of the American Heart Association (2024)
Junxing Chay, Tazeen Hasan Jafar, Rebecca Jade Su, Rupesh Madhukar Shirore, Ngiap Chuan Tan, Eric Andrew Finkelstein
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension. Journal of the American Heart Association 13 (8) (2024)
Junxing Chay, Jason Chon Jun Choo, Eric Andrew Finkelstein
Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore. Nephrology (Carlton, Vic.) 29 (5) (2024)
Junxing Chay, Tazeen Hasan Jafar, Rebecca Jade Su, Rupesh Madhukar Shirore, Ngiap Chuan Tan, Eric Andrew Finkelstein
Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension. Journal of the American Heart Association 13 (8) (2024)
Junxing Chay, Joshua Yi Min Tung, Rebecca Jade Su, Edwin Jonathan Aslim, Callix Wong, Georgia Swan, Wei Jin Chua, Henry Sun Sien Ho, Eric Andrew Finkelstein
Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore. Journal of medical economics (2023)
Junxing Chay, Rachael Wei Chao Tang, Tien-En Tan, Choi Mun Chan, Ranjana Mathur, Brian J H Lee, Hiok Hong Chan, Shaun Sebastian Khung Peng Sim, Saadia Farooqui, Kelvin Yi Chong Teo, Eva K Fenwick, Ecosse L Lamoureux, Chui Ming Gemmy Cheung, Beau J Fenner
The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study. Eye (London, England) (2023)
Junxing Chay, Seonghoon Kim
Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States. Health economics (2021)
Junxing Chay, Beau J Fenner, Eric A Finkelstein, Kelvin Yi Chong Teo, Chui Ming Gemmy Cheung
Real-world cost-effectiveness of anti-VEGF monotherapy and combination therapy for the treatment of polypoidal choroidal vasculopathy. Eye (London, England) (2021)